Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Employment agrmnt
Quarterly results
Auditor change
Consulting agrmnt
|
|
PIERIS PHARMACEUTICALS, INC. (PIRS)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/30/2023 |
4
| KIRITSY CHRISTOPHER P (Director) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.|
Txns:
| Bought 10,000 shares
@ $0.85, valued at
$8.5k
|
|
| 02/28/2023 |
4
| Bures Thomas (CFO) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.|
Txns:
| Granted 249,080 options to buy
@ $1.39, valued at
$346.2k
|
|
| 02/28/2023 |
4
| Kaufmann Hitto (Chief Scientific Officer) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.|
Txns:
| Granted 249,080 options to buy
@ $1.39, valued at
$346.2k
|
|
| 02/28/2023 |
4
| Mousa Ahmed (Chief Business Officer) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.|
Txns:
| Granted 249,080 options to buy
@ $1.39, valued at
$346.2k
|
|
| 02/28/2023 |
4
| Yoder Stephen S. (CEO) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.|
Txns:
| Granted 634,021 options to buy
@ $1.39, valued at
$881.3k
|
|
| 06/24/2022 |
4
| Barbier Ann (Director) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.|
Txns:
| Granted 40,000 options to buy
@ $1.82, valued at
$72.8k
|
|
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Kiener Peter A (Director) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.|
Txns:
| Granted 40,000 options to buy
@ $1.82, valued at
$72.8k
|
|
| 06/24/2022 |
4
| KIRITSY CHRISTOPHER P (Director) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.|
Txns:
| Granted 40,000 options to buy
@ $1.82, valued at
$72.8k
|
|
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Sherman Matthew L (Director) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.|
Txns:
| Granted 40,000 options to buy
@ $1.82, valued at
$72.8k
|
|
| 05/16/2022 |
4
| Demuth Tim (Chief Medical Officer) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.|
Txns:
| Bought 6,000 shares
@ $1.71, valued at
$10.3k
|
|
| 02/24/2022 |
4
| Demuth Tim (Chief Medical Officer) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.|
Txns:
| Granted 100,000 options to buy
@ $3.03, valued at
$303k
|
|
| 02/24/2022 |
4
| Mousa Ahmed (Chief Business Officer) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.|
Txns:
| Granted 215,819 options to buy
@ $3.03, valued at
$653.9k
|
|
| 02/24/2022 |
4
| Olwill Shane (Chief Development Officer) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.|
Txns:
| Granted 215,819 options to buy
@ $3.03, valued at
$653.9k
|
|
| 02/24/2022 |
4
| Bures Thomas (CFO) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.|
Txns:
| Granted 215,819 options to buy
@ $3.03, valued at
$653.9k
|
|
| 02/24/2022 |
4
| Kaufmann Hitto (SVP, Chief Scientific Officer) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.|
Txns:
| Granted 215,819 options to buy
@ $3.03, valued at
$653.9k
|
|
| 02/24/2022 |
4
| Yoder Stephen S. (CEO) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.|
Txns:
| Granted 625,874 options to buy
@ $3.03, valued at
$1.9M
|
|
| 09/01/2021 |
4
| Olwill Shane (Chief Development Officer) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.|
Txns:
| Sold 9,200 shares
@ $5, valued at
$46k
Sold 29,200 shares
@ $5.15, valued at
$150.4k
Exercised 38,400 options to buy
@ $1.52, valued at
$58.4k
|
|
| 08/03/2021 |
4
| Demuth Tim (Chief Medical Officer) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.|
Txns:
| Granted 360,000 options to buy
@ $3.48, valued at
$1.3M
|
|
| 06/29/2021 |
4
| Sherman Matthew L (Director) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.|
Txns:
| Granted 40,000 options to buy
@ $4, valued at
$160k
|
|
| 06/29/2021 |
4
| Said Maya R. (Director) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.|
Txns:
| Granted 40,000 options to buy
@ $4, valued at
$160k
|
|
| 06/29/2021 |
4
| Richman Michael (Director) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.|
Txns:
| Granted 40,000 options to buy
@ $4, valued at
$160k
|
|
| 06/29/2021 |
4
| KIRITSY CHRISTOPHER P (Director) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.|
Txns:
| Granted 40,000 options to buy
@ $4, valued at
$160k
|
|
| 06/29/2021 |
4
| Kiener Peter A (Director) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.|
Txns:
| Granted 40,000 options to buy
@ $4, valued at
$160k
|
|
| 06/29/2021 |
4
| GERAGHTY JAMES A (Director) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.|
Txns:
| Granted 45,000 options to buy
@ $4, valued at
$180k
|
|
| 06/29/2021 |
4
| Barbier Ann (Director) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.|
Txns:
| Granted 40,000 options to buy
@ $4, valued at
$160k
|
|
| 03/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/22/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/25/2020 |
4
| Sherman Matthew L (Director) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.|
Txns:
| Granted 40,000 options to buy
@ $3.27, valued at
$130.8k
|
|
|
|
|